CIBC Asset Management Inc Boosts Stake in Astera Labs, Inc. $ALAB

CIBC Asset Management Inc grew its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 41.0% in the 4th quarter, HoldingsChannel.com reports. The fund owned 6,838 shares of the company’s stock after acquiring an additional 1,988 shares during the period. CIBC Asset Management Inc’s holdings in Astera Labs were worth $1,138,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Royal Bank of Canada grew its holdings in shares of Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC raised its holdings in Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares during the period. Empowered Funds LLC raised its holdings in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares during the period. First Trust Advisors LP lifted its position in Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. grew its stake in Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after buying an additional 1,977 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Trading Up 9.2%

NASDAQ ALAB opened at $346.33 on Tuesday. The company’s fifty day simple moving average is $217.60 and its 200-day simple moving average is $173.27. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $372.37. The stock has a market cap of $59.36 billion, a P/E ratio of 234.01, a PEG ratio of 4.20 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same period last year, the business earned $0.33 EPS. The business’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Wall Street Analyst Weigh In

ALAB has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Roth Mkm reaffirmed a “buy” rating and set a $275.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. TD Cowen increased their price target on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Needham & Company LLC raised their price objective on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Finally, Susquehanna boosted their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Insider Activity at Astera Labs

In other news, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the sale, the general counsel directly owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 2,321,256 shares of company stock valued at $480,893,146. 10.40% of the stock is currently owned by insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.